{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urticaria&page=8", "query": { "condition": "Urticaria", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 224, "total_pages": 23, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urticaria&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Urticaria&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T02:36:13.648Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06343779", "title": "Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hereditary Angioedema", "Hereditary Angioedema Type I", "Hereditary Angioedema Type II", "Hereditary Angioedema Types I and II", "Hereditary Angioedema Attack", "Hereditary Angioedema With C1 Esterase Inhibitor Deficiency", "Hereditary Angioedema - Type 1", "Hereditary Angioedema - Type 2", "C1 Esterase Inhibitor [C1-INH] Deficiency", "C1 Esterase Inhibitor Deficiency", "C1 Esterase Inhibitor, Deficiency of", "C1 Inhibitor Deficiency", "Hereditary Angioedema - Type 3", "Hereditary Angioedema Type III" ], "interventions": [ { "name": "Deucrictibant, Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pharvaris Netherlands B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 134, "start_date": "2024-02-26", "completion_date": "2025-10-17", "has_results": false, "last_update_posted_date": "2025-11-21", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Paradise Valley, Arizona • Little Rock, Arkansas + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06343779" }, { "nct_id": "NCT00097695", "title": "Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Angioedema" ], "interventions": [ { "name": "Icatibant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2004-12-28", "completion_date": "2006-07-17", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097695" }, { "nct_id": "NCT06868212", "title": "A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Spontaneous Urticaria (CSU)" ], "interventions": [ { "name": "Remibrutinib", "type": "DRUG" }, { "name": "Remibrutinib matching placebo", "type": "DRUG" }, { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo solution for injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 409, "start_date": "2025-07-11", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 121, "location_summary": "Birmingham, Alabama • Litchfield Park, Arizona • Payson, Arizona + 98 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Payson", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06868212" }, { "nct_id": "NCT05795153", "title": "A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Spontaneous Urticaria" ], "interventions": [ { "name": "LOU064", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 144, "start_date": "2023-04-05", "completion_date": "2024-04-25", "has_results": true, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • Aventura, Florida • Greenacres City, Florida + 7 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aventura", "state": "Florida" }, { "city": "Greenacres City", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Glenview", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05795153" }, { "nct_id": "NCT05477160", "title": "A Study of STAR-0215 in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hereditary Angioedema" ], "interventions": [ { "name": "STAR-0215 (SC)", "type": "DRUG" }, { "name": "Placebo (SC)", "type": "DRUG" }, { "name": "STAR-0215 (IV)", "type": "DRUG" }, { "name": "Placebo (IV)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astria Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 41, "start_date": "2022-07-27", "completion_date": "2023-11-17", "has_results": false, "last_update_posted_date": "2024-01-11", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05477160" }, { "nct_id": "NCT01981499", "title": "A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "PF-05180999", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "120 mg MR PF-05180999", "type": "DRUG" }, { "name": "360 mg MR PF-05180999", "type": "DRUG" }, { "name": "10 mg cetirizine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 31, "start_date": "2014-01", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2014-05-08", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01981499" }, { "nct_id": "NCT00619801", "title": "Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Allergic Rhinitis", "Chronic Urticaria" ], "interventions": [ { "name": "Levocetirizine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "2 Years to 6 Years" }, "enrollment_count": 173, "start_date": "2008-03", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2015-03-06", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 25 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Crescent City", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00619801" }, { "nct_id": "NCT07046806", "title": "Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hereditary Angioedema (HAE)", "Angioedema", "Bradykinin-mediated Angioedema", "C1 Inhibitor Deficiency" ], "interventions": [ { "name": "Deucrictibant XR tablet", "type": "DRUG" }, { "name": "Placebo comparator to XR tablet", "type": "DRUG" }, { "name": "Deucrictibant 20 mg capsule", "type": "DRUG" }, { "name": "Placebo comparator to 20 mg capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Institute for Asthma and Allergy", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 10, "start_date": "2025-03-10", "completion_date": "2026-04-01", "has_results": false, "last_update_posted_date": "2025-07-02", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 1, "location_summary": "Wheaton, Maryland", "locations": [ { "city": "Wheaton", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07046806" }, { "nct_id": "NCT02303626", "title": "12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Hereditary Angioedema", "HAE" ], "interventions": [ { "name": "BCX4161", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2014-12-17", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Granada Hills, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Granada Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02303626" }, { "nct_id": "NCT00438815", "title": "Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hereditary Angioedema" ], "interventions": [ { "name": "C1 esterase inhibitor [human] (C1INH-nf)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 113, "start_date": "2006-09-21", "completion_date": "2009-03-31", "has_results": true, "last_update_posted_date": "2021-06-08", "last_synced_at": "2026-10-22T02:36:13.648Z", "location_count": 30, "location_summary": "Scottsdale, Arizona • Bentonville, Arkansas • Los Angeles, California + 27 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bentonville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00438815" } ] }